Insights from 2023 ASH Annual Meeting
J

ASH 2023 Insights: "Limited Duration Loncastuximab Tesirine With Rituximab in High-Risk R/R Follicular Lymphoma"

By Insights from 2023 ASH Annual Meeting FEATURING Juan Pablo Alderuccio
By Insights from 2023 ASH Annual Meeting FEATURING Juan Pablo Alderuccio
40 views
December 15, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
19:46
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Management of Indolent NHL

Feat. E. Brem
08:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…

Feat. C. Flowers
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
10:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…

Feat. R. Merryman
04:16
GRACE

Mosunetuzumab for R/R Follicular Lymphoma

Feat. T. Phillips
42:09
University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

Feat. M. Kamdar
03:33
PrecisCa

Mosunetuzumab in R/R Follicular Lymphoma

Feat. M. Kamdar
27:49
MyCancerHaven

Overview of the Diagnosis and Treatment of Follicular Lymphoma

Feat. R. Vij, T. Fehniger
21:19
MyCancerHaven

Experts Discuss the Use of Bispecific Antibodies in NHL

Feat. R. Vij, B. Kahl
15:08
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…

Feat. L. Nastoupil
17:19
SOHO Turkey 2023

SOHO Turkey 2023: How I Treat Follicular Lymphoma

Feat. J. Lister
15:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Lymphoma Bispecific Antibody Therapy and Management of CRS

Feat. D. Land, M. Hughes
03:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation,…

Feat. G. Perini
11:12
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: Indolent B-Cell Lymphoma

Feat. L. Nastoupil